STN International ® CAPLUS Database, Compound I, Gustafson et al., Tetrahedron Lett. (1994), 35(32), 5821-4, abstract.* |
Brookmeyer, R. (1991), Science, vol. 253, pp. 37-42. |
Braun et al. (1990), Annu. Rev. Microbiol., vol. 44, pp. 555-577. |
Braun, et al., “The Global Epidemiology of HIV Infection and Aids,” Annu. Rev. Microbiol., vol. 44, 1990, pp. 555-577. |
Borch, et al., “The Cyanohydriboborate Anion as a Selective Reducing Agent,” Journal of American Chemical Society, vol. 93 [12], 1971, pp. 2897-2904. |
Buckheit, et al. “Resistance to 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine Derivatives is Generated by Mutations at Multiple Sites in the HIV-1 Reverse Transcriptase,” Virology, vol. 210, 1995, pp. 186-193. |
Buckheit, et al., “Cell-based and biochemical analysis of the anti-HIV activity of combinations of 3′ -azido-3′ -deoxythymidine and analogues of TIBO,” Antiviral Chemistry & Chemotherapy, vol. 5[1], 1994, pp. 35-42. |
Brookmeyer, “Reconstruction and Future Trends of the AIDS Epidemic in the United States,” Science, vol. 253, 1991, pp. 37-42. |
Feuer, et al., “The Reduction of Oximes, Oxime Ethers, and Oxime Esters with Diborane. A Novel Synthesis of Amines,” Journal of Organic Chemistry, vol. 34 [6], 1969, pp. 1817-1821. |
Feuer, et al., “The Reduction of Oximes with Diborane. A New Synthesis of N-Monosubstituted Hydroxylamines,” The Journal of Organic Chemistry, vol. 30 [9], 1965, pp. 2877-2880. |
Fung, et al., “Reduction by Tributyltin Hydride of Carbonyl Compounds Adsorbed on Silica Gel: Selective Reduction of Aldehydes,” J. Org. Chem., vol. 43 [20], 1978, pp. 3977-3979. |
Gemal, et al., “Lanthanoids in Organic Synthesis. 6. The Reduction of x-Enones by Sodium Borohydride in the Presence of Lanthanoid Chlorides: Synthetic and Mechanistic Aspects,” Journal of American Chemical Society, vol. 103, 1981, pp. 5454-5459. |
Gustafson, et al., “A nonpromoting Phorbol from the Samoan Medicinal Plant Homalanthus nutans Inhibits Cell Killing by HIV-1,” Journal of Medicinal Chemistry, vol. 35 [11], 1992, pp. 1978-1986. |
Hertzberg, et al., “Novel Methods for Antiviral Drug Discovery,” Third International Conference on the Biotechnology of Microbial Products, 1993, S-9 (Abstract Only). |
Huff, J., “HIV Protease: A Novel Chemotherapeutic Target for AIDS,” Journal of Medicinal Chemistry, vol. 34 [8], 1991, pp. 2305-2314. |
Hughes, D., “The Mitsunobu Reaction,” Organic Reactions, vol. 42, 1992, pp. 335-657. |
Khilevich, et al., “Synthesis Of (+)-Calanolide A, AN Anti-HIV Agent, Via Enzyme-Catalyzed Resolution Of The Aldol Products,” Tetrahedron Assymmetry, vol. 7 [11], 1996, pp. 33315-3326. |
Kukla, et al., “Synthesis and Anti-HIV-1 Activity of 4,5,6,7-Tetrahydro-5-methylamidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) Derivatives,” Journal of Medicinal Chemistry, vol. 34 [2], 1991, pp. 746-751. |
Lin, et al., “Synthesis and Biological Evaluation of 2′,3′-Dideoxy-L-pyrimidine Nucleosides as Potential Antiviral Agents against Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV),” Journal of Medicinal Chemistry, vol. 37 [6], 1994, pp. 798-803. |
McCaffrey, et al., “A Rapid Fluorometric DNA Assay for the Measurement of Cell Density and Proliferation In Vitro,” In Vitro Cellular & Developmental Biology, vol. 24 [3] Part I, 1988, pp. 247-252. |
McGuigan, et al., “Synthesis and anti-HIV activity of some novel diaryl phosphate derivatives of AZT,” Antiviral Research, vol. 24, 1994, pp. 69-77. |
McMahon, et al., “Diarylsulfones, a New Chemical Class of Nonnucleoside Antiviral Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase,” Antimicrobial Agents and Chemotherapy, vol. 37 [4], 1993, pp. 754-760. |
Massa, et al., “Synthesis and antiviral activity of new 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), specific inhibitors of human immunodeficiency virus type 1,” Antiviral Chemistry & Chemotherapy, vol. 6 [1], 1995, pp. 1-8. |
Mayaux, et al., “Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells,” Proc. Natl. Acad. Sci. USA, vol. 91, 1994, pp. 3564-3568. |
Meier, et al., “O-Alkyl-5′,5′-dinucleoside Phosphates as Prodrugs of 3′-Azidothymidine and Cordycepin1,” J. Org. Chem., vol. 57 [26], 1992, pp. 7300-7308. |
Merigan, T., “Treatment of AIDS with Combinations of Antiretroviral Agents,” The American Journal of Medicine, vol. 90 [4A], 1991, pp. 4A-8S-4A-18S. |
Weislow et al. (1989), J. Natl. Cancer Inst., vol. 81, 577-586. |
Mitsuya et al. (1990), Science, vol. 249, pp. 1533-1544. |
Petteway et al. (1991), Trends Pharmacol. Sci., vol. 12, pp. 28-34. |
Richman, D.D. (1991), Annu. Rev. Med., vol. 42, pp. 69-90. |
Huff, J.R. (1991), J. Med. Chem., vol. 34, pp. 2305-2314. |
De Clercq, E. (1992), AIDS Research and Human Retroviruses, vol. 8, pp. 119-134. |
Kashman et al. (1992), J. Med. Chem., vol. 35, pp. 2735-2743. |
Chenera et al. (1993), J. Org. Chem., vol. 58, pp. 5605-5606. |
Sethna et al. (1953), Organic Reactions, Chapter 1, pp. 1-58. |
Crombie et al. (1987), J. Chem. Soc., Perkins Trans. I., pp. 317-330. |
Barton et al. (1990), Tetrahedron Letters, vol. 31, pp. 7449-7452. |
Széll et al. (1969), Helvetica Chimica Acta, vol. 52, pp. 2636-2641. |
Fung et al. (1978), J. Org. Chem., vol. 43, pp. 3977-3979. |
Gemal et al. (1981), J. Am. Chem. Soc., vol. 103, pp. 5454-5459. |
Palmer et al. (1994), “Synthesis of the Calophyllum coumarins,” Tet. Letters, vol. 35, pp. 5363-5366. |
Games et al. (1972), “Identification of 4-Phenyl and 4-Alkycoumarins in Mammea Americana L., Mammea Africana G. Don and Calophyllum Inophyllum by Gas Chromatography-Mass Spectrometry,” Tet. Letters, vol. 31, pp. 3187-3190. |
Crombie et al. (1966), “Isolation and Structure of Mammea B/BA, B/BB, B/BC and C/BB: A Group of 4-m-Propyl- and 4-n-Amyl-Coumarin Extractives of Mammea Americana L.,” Tet. Letters, vol. 2, pp. 151-156. |
Hizi et al. (1993), “Specific Inhibition of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 and the Chimeric Enzymes of Human Immunodeficiency Virus Type 1 and Type 2 by Nonnuceloside Inhibitors,” Antimicrobial Agents and Chemotherapy, vol. 37, pp. 1037-1042. |
Buckheit et al., (1995), Anti-Viral Research, vol. 26, pp. 117-132. |
Boyer et al. (1993), “Analysis of Nonnucleoside Drug-Resistant Variants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase,” J. Virology, vol. 67, pp. 2412-2420. |
McKee et al. (1995), “The Pseudocalanolides: Structure Revision of Calanolides C and D,” J. Natural Products, vol. 58, pp. 916-920. |
Kucherenko et al. (1995), “Novel Approach for Synthesis of (±)-Calanolide A and Its Anti-HIV Activity,” Tet. Letters, vol. 36, pp. 5475-5478. |
Gustafson et al. (1994), “Calanone, a Novel Coumarin From Calophyllum teysmannii,” Tet. Letters, vol. 35, pp. 5821-5824. |
Kashman et al. (1993), “The Calanolides, a Novel HIV-Inhibitory Class of Coumarin Derivatives from the Tropical Rainforest Tree, Calophyllum lanigerum,” J. Med. Chem., vol. 36, pp. 1110. |
Bader et al. (1991), “Oxathiin Carboxanilide, a Potent Inhibitor of Human Immunodeficiency Virus Reproduction,” Proc. Natl. Acad. Sci. USA, vol. 88, pp. 6740-6744. |
Borch et al. (1971), “The Cyanohydridoborate Anion as a Selective Reducing Agent,” J. Amer. Chem. Soc., vol. 93, pp. 2897-2904. |
Buckheit et al. (1994), “Cell-Based and Biochemical Analysis of the Anti-HIV Activity of Combination of 3′-Azido-3′-Deoxythymidine and Analogues of TIBO,” Antiviral Chemistry & Chemotherapy, vol. 5(1), pp. 35-42. |
Castro, B.R. (1983), “Replacement of Alcoholic Hydroxyl Groups by Halogens and Other Nucleophiles via Oxyphosphonium Intermediates,” Org. React., vol. 29, pp. 1-162. |
Feuer et al. (1965), “The Reduction of Oximes with Diborane. A New Synthesis of N-Monosubstituted Hydroxylamines,” J. Org. Chem., vol. 30, pp. 2877-2880. |
Feuer and Braunstein (1969), “The Reduction of Oximes, Oxime Ethers, and Oxime Esters with Diborane. A Novel Synthesis of Amines,” J. Org. Chem., vol. 34, pp. 1817-1821. |
Hudlicky, M. (1988), “Fluorination with Diethylaminosulfur Trifluoride and Related Aminofluorosulfuranes,” Org. React., vol. 35, pp. 513-637. |
Hughes, D.L. (1992), “The Mitsunobu Reaction,” Organic Reaction, vol. 42, pp. 335-656. |
Kukla et al. (1991), “Synthesis and Anti-HIV-1 Activity of 4,5,6,7-Tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) Derivatives,” J. Medicinal Chemistry, vol. 34, pp. 746-751. |
Lin et al. (1994), “Synthesis and Biological Evaluation of 2′,3′-Dideoxy-L-pyrimidine Nucleosides as Potential Antiviral Agents Against Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV),” J. Med. Chem., vol. 37, pp. 798-803. |
Massa et al. (1995), “Synthesis and Antiviral Activity of New 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), Specific Inhibitors of Human Immunodeficiency Virus Type 1,” Antiviral Chemistry and Chemotherapy, vol. 6, pp. 1-8. |
Mayaux et al. (1994), “Triterpene Derivatives that Block Entry of Human Immunodeficiency Virus Type 1 Into Cells,” Proc. Natl. Acad. Sci. USA, vol. 91, pp. 3564-3568. |
McGuigan et al. (1994), “Synthesis and Anti-HIV Activity of Some Novel Diaryl Phosphate Derivatives of AZT,” Antiviral Research, vol. 24, pp. 69-77. |
McMahon et al. (1993), “Diarylsulfones, a New Chemical Class of Nucleoside Antiviral Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase,” Antimicrobial Agents and Chemotherapy, vol. 37, pp. 754-760. |
Meier et al. (1992), “O-Alkyl-5′,5′-dinucleoside Phosphates as Prodrugs of 3′-Azidothymidine and Cordycepin,” J. Org. Chem., vol. 57, pp. 7300-7308. |
Merluzzi et al. (1990), “Inhibition of HIV-1 Replication by a Nucleoside Reverse Transcriptase Inhibitor,” Science, vol. 250, pp. 1411-1413. |
Mitsunobu, O. (1981), “The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products,” Synthesis, pp. 1-28. |
Miyasaka et al. (1989), “A Novel Lead for Specific Anti-HIV-1 Agents: 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)-thymine,” J. Medicinal Chemistry, vol. 32, pp. 2507-2509. |
Nielsen and Houlihan (1968), “The Aldol Condensation,” Org. React., vol. 16, pp. 1-438. |
Pauwels et al. (1990), “Potent and Selective Inhibition of HIV-1 Replication In Vitro by a Novel Series of TIBO Derivatives,” Nature, vol. 343, pp. 470-474. |
Pauwels et al. (1988), “Rapid and Automated Tetrazolium-Based Colorimetric Assay for the Detection of Anti-HIV Compounds,” J. Virological Methoods, vol. 309-321. |
Sergheraert et al. (1993), Synthesis and Anti-HIV Evaluation of D4T and D4T 5′-Monophosphate Prodrugs, J. Medicinal Chemistry, vol. 36, pp. 826-830. |
Wasserman et al. (1989), “The Chemistry of Vicinal Tricarbonyls, Use of Vinyl Tricarbonyl Esters in the Formation of 3-Hydroxypyrrole-2-Carboxylates,” Tet. Letters, vol. 30, pp. 1721-1724. |
Bandara et al. (1986), “Two Chemically Distinct Groups of Calophyllum Species From Sri Lanka,” Phytochemistry, vol. 25, pp. 425-428. |
Ríos, et al., “Effect of interferon and 2′,5′-oligoadenylates on rotavirus RNA synthesis,” Antiviral Research, vol. 26, 1995, pp. 133-143. |
Chaturvedi et al. (1974), “Anticonvulsant and Antinflammatory Activity of Natural Plant Coumarins and Triterpenoids,” Res. Communications in Chemical Pathology and Pharmacology, vol. 9, pp. 11-22. |
Craig et al. (1991), “Antiviral Properties of Ro 31-8959, An Inhibitor of Human Immunodeficiency Virus (HIV) Proteinase,” Antiviral Research, vol. 16, pp. 295-305. |
Dahanayake et al. (1974), “Chemical Investigation of Ceylonese Plants. Part VII. Extractives of Calophyllum thwaitesii Planch and Triana and Calophyllum walkeri Wight (Guttiferae),” J.C.S. Perkin I, pp. 2510-2514. |
Dharmaratne et al. (1985), “Triterpenoids and Coumarins from the Leaves of Calophyllum cordato-oblongum,” Phytochemistry, vol. 24, pp. 1553-1556. |
Dharmaratne et al. (1986), “Xanthones from Roots of Three Calophyllum Species,”Phytochemistry, vol. 25, pp. 1957-1959. |
Gunasekera et al. (1977), “Chemical Investigation of Ceylonese Plants. Part 27. Extractives of Calophyllum cuneifolium Thw. and Calophyllum soulattri Burm. F. (Guttiferae),” J.C.S. Perkin I, pp. 1505-1511. |
Gunasekera et al. (1975), “Chemical Investigation of Ceylonese Plants. Part XVI. Extractives of Calophyllum cardato-oblongum Thw. (Guttiferae),” J.C.S. Perkin I, pp. 2215-2220. |
Gunatilaka et al. (1984), “Terpenoid and Biflavanoid Constituents of Calophyllum calaba and Garcinia spicata From Sri Lanka,” Phytochemistry, vol. 23, pp. 323-328. |
Gustafson et al. (1992), “A Nonpromoting Phorbol from the Samoan Medicinal Plant Homalanthus nutans Inhibits Cell Killing by HIV-1,” J. Med. Chem., vol. 35, pp. 1978-1986. |
Gustafson et al. (1992), “AIDS-Antiviral Natural Products Research at the U.S. National Cancer Inst.,” in Natural Products as Antiviral Agents, Chu et al., eds. Plenum Press, New York, 1992, pp. 57-67. |
Kawazu et al. (1972), “Piscicidal Constituents of Capophyllum inophyllum,” Chemical Abstracts, vol. 78, Abstract No. 13744F. |
Kumar et al. (1982), “Calocalabaxanthone, The Putative Isoprenyl Precursor of Calabaxanthone From Calophyllum calaba,” Phytochemistry, vol. 21, pp. 807-809. |
Merigan et al. (1991), “Treatment of AIDS with Combinations of Antiretroviral Agents,” Am. J. of Medicine, vol. 90, pp. 8S-17S. |
McCaffrey et al. (1988), “A Rapid Fluorometric DNA Assay for the Measurement of Cell Density and Proliferation In Vitro,” In Vitro Cellular & Developmental Biology, vol. 24, Part I, pp. 247-252. |
Ohtani et al. (1991), “A New Aspect of the High-Field of NMR Application of Mosher's Method. The Absolute Confirugation of Marine Triterpene Sipholenol-A,” J. Org. Chem., vol. 56, pp. 1296-1298. |
Ohtani et al. (1989), “Absolute Configuration of Marine Diterpenes Possessing a Xenicane Skelton. An Application of an Advanced Mosher's Method,” Tetrahedron Letters, vol. 30, pp. 3147-3150. |
Rink et al. (1982), “Cytoplasmic pH and Free Mg2+ in Lymphocytes,” J. of Cell Biology, vol. 95, pp. 189-196. |
Samaraweera et al. (1981), “Calozeylanic Acid, A New Bark Acid From Three Calophyllum Species,” Tetrahedron Letters, vol. 22, pp. 5083-5086. |
Saunders et al. (1992), “Non-nucleoside Inhibitors of HIV reverse Transcriptase,” Drug Design and Discovery, vol. 8, pp. 255-263. |
Shih et al. (1991), “Chimeric Human Immunodeficiency Virus Type 1/Type 2 Reverse Transcriptases Display Reversed Sensitivity to Nonnucleoside Analog Inhibitors,” Proc. Natl. Acad. Sci. USA, vol. 88, pp. 9878-9882. |
Stout et al. (1968), “Calophyllum Products III. The Structures of Blancoic Acids,” J. Organic Chemistry, vol. 33, pp. 4185-4190. |
Stout et al. (1964), “The Structure of Costatolide,” J. Organic Chemistry, vol. 29, pp. 3604-3609. |
Swagler et al. (1991), “Pharmacokinetics of Anti-HIV Nucleosides in Microswine,” J. Pharm. Pharmacol., vol. 43, pp. 823-826. |
Somanathan et al. (1974), “Chemical Investigation of Ceylonese Plants. Part VIII. Trapezifolixanthone, a New Di-isoprenylated Xanthone from the Bark of Calophyllum trapezifolium Thw. (Guttiferae),” J.C.S. Perkin I, pp. 2515-2517. |
White et al. (1991), “A TIBO Derivative, R82913, Is A Potent Inhibitor of HIV-1 Reverse Transcriptase with Heteropolymer Templates,” Antiviral Research, vol. 16, pp. 257-266. |
Cragg et al. (1993), Conservation of Biodiversity and the Potetntial for Development of Pharmaceutical Crops: Drug Discovery and Development at the United States National Cancer Institute, In Proceedings of the Symposium on the Industrial Utilization of Tropical Plants and the Conservation of Biodiversity, Enugu, Nigeria, Feb. 14-19. |
Hertzberg et al. (1933), “Kinetic Studies of HIV-1 Reverse Transcriptase Inhibition by Inophyllums, A Novel Class of Non-Nucleoside Inhibitors, Using a Scintillation Proximity Assay,” Programs and Abstracts of the Third International Conference on the Biotechnology of Microbial Products: Novel Pharmacological and Agrobiological Activities, P-42, Apr. 27, 1993. |
Hertzberg et al. (1993), “Novel Methods for Antiviral Drug Discovery,” Programs and Abstracts of the Third International Conference on the Biotechnology of Microbial Products: Novel Pharmacological and Agrobiological Activities, S-9, Apr. 17, 1993. |
Mabberley, D.J. (1987), The Plant Book, Cambridge University Press, p. 92. |
Patil et al. (1993), “The Inophyllums, Novel Inhibitors of HIV-1 Reverse Transcriptase,” Programs and Abstracts of the Third International Conference on the Biotechnology of Microbial Products: Novel Pharmacological and Agrobiological Activities, P-31, Apr. 26, 1993. |
Crombie et al. (1987), Synthesis of Mammeins and Surangin A, J. Chem. Soc. Perkins Trans. I., p. 317-331. |
Khilevich, et al., “A versatile approach for synthesis of 2,3-dimethylochroman-4-ones, intermediate for calanolide anti-HIV agents, via aldol/Mitsunobu reactions,” Chemical Abstracts: 26-Biomolecules and Their Synthetic Analogs, vol. 125 [21], 1996, Abstract No. 275454w, pp. 1216. |
Khilevich, et al., “Synthesis Of (+)-Calanolide A., An Anti-HIV Agent, Via Enzyme-Catalyzed Resolution of the Aldol Products,” Tetrahedron: Asymmetry, vol. 7 [11], 1996, pp. 3315-3326. |
Palmer, et al., “Synthesis of the Calophyllum coumarins. Part 21,” J. Chem. Soc. Perkin Trans. I., vol. 1, 1995, pp. 3135-3152. |
Galinis, et al., “Structure-Activity Modifications of the HIV-1 Inhibitors (+)-Calanolide A and (−)-Calanolide B1,” J. Med. Chem., vol. 39, 1996, pp. 4507-4510. |
Zembower, et al., Structural Analogues of the Calanolide Anti-HIV Agents. Modifications of the trans-10,11-Dimethyldihydropyran-12-ol Ring (Ring C)1, J. Med. Chem., vol. 40, 1997, pp. 1005-1017. |
Hadden, J., “TIPS Reviews: Immunotherapy of human immunodeficiency virus infection,” TiPS, vol. 12, Mar. 1991, pp. 107-111. |
Cooper et al. (1994), GR15987 and Related Analogues as Highly Potent, Orally Active Non-Peptide Neurokinin NK2 Receptor Antagonists, Bioorganic & Med. Chem. Lett., vol. 4, pp. 1951-1956. |
Chemical Abstracts, vol. 125, 1996, p. 979, Abstract No. 300646v. |